Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.4 EUR
99.03 M EUR
1.40 B EUR
22.92 M
About TOWA PHARMACEUTICAL CO
Sector
Industry
Website
Headquarters
Kadoma
Founded
1951
ISIN
JP3623150004
FIGI
BBG01103SBW9
Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include neurological and anti-allergic drugs, cardiovascular and respiratory drugs, gastrointestinal drugs, antibiotics and chemotherapeutic drugs, vitamins, hormone drugs, and other metabolic drugs. It operates through Domestic and Overseas Segments. The Domestic segment manufacture and sale of pharmaceuticals directly to medical institutions through sales offices, as well as to agents, pharmaceutical wholesalers, and other pharmaceutical manufacturers. The Overseas segment engages in generic pharmaceutical sales business; contract research; and development and manufacturing business. The company was founded in June 1951 and is headquartered in Kadoma, Japan.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange TOWA PHARMA. CO. stocks are traded under the ticker 6QC.
We've gathered analysts' opinions on TOWA PHARMA. CO. future price: according to them, 6QC price has a max estimate of 28.37 EUR and a min estimate of 18.50 EUR. Watch 6QC chart and read a more detailed TOWA PHARMA. CO. stock forecast: see what analysts think of TOWA PHARMA. CO. and suggest that you do with its stocks.
Yes, you can track TOWA PHARMA. CO. financials in yearly and quarterly reports right on TradingView.
TOWA PHARMA. CO. is going to release the next earnings report on May 15, 2025. Keep track of upcoming events with our Earnings Calendar.
6QC earnings for the last quarter are 1.01 EUR per share, whereas the estimation was 0.35 EUR resulting in a 184.31% surprise. The estimated earnings for the next quarter are 0.70 EUR per share. See more details about TOWA PHARMA. CO. earnings.
TOWA PHARMA. CO. revenue for the last quarter amounts to 432.10 M EUR, despite the estimated figure of 430.69 M EUR. In the next quarter, revenue is expected to reach 427.25 M EUR.
6QC net income for the last quarter is 49.57 M EUR, while the quarter before that showed 6.62 M EUR of net income which accounts for 648.46% change. Track more TOWA PHARMA. CO. financial stats to get the full picture.
TOWA PHARMA. CO. dividend yield was 2.07% in 2023, and payout ratio reached 18.26%. The year before the numbers were 3.17% and 134.18% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 23, 2025, the company has 4.59 K employees. See our rating of the largest employees — is TOWA PHARMA. CO. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TOWA PHARMA. CO. EBITDA is 261.04 M EUR, and current EBITDA margin is 15.59%. See more stats in TOWA PHARMA. CO. financial statements.
Like other stocks, 6QC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TOWA PHARMA. CO. stock right from TradingView charts — choose your broker and connect to your account.